More than 100 million people in the U.S. have some allergy each year. That’s about every 1 in 3 adults. For many, the fix is ...

First study participant dosed in U.S. trial with healthy volunteers and patients with peanut allergy Novel, human-derived, ...

Traditional allergy treatments are known to be inconvenient. For people who rely on immunotherapy, the process often involves routine visits to a clinic for allergy shots—a commitment that can last ...

Allergy shots and drops offer a transformative solution for millions. Major health organisations globally endorse this ...

If you live with environmental allergies that disrupt your daily life, Curex's immunotherapy treatment may help. Immunotherapy slowly exposes you to small doses of allergens so your body becomes less ...

Before allergy medicine, there were a whole slew of bizarre ways to treat symptoms of what was known in the late 1800s as "hay fever." The term "allergy" didn't exist until 1906, says Theresa MacPhail ...

Australia, the ‘allergy capital of the world,’ has launched a world-first free nationwide treatment program for children with peanut allergies. The goal is to safely build tolerance to the troublesome ...

Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...

Experts found that younger patients are more likely to achieve full remission. A peanut allergy treatment often used on children 4 years old and up in the U.S. appears to be safe for toddlers too, a ...

Childhood peanut allergies are increasing in the U.S. This is a Kaiser Health News story. Whenever I see a report touting possible new peanut allergy treatments, I devour it. I can’t help it. It’s an ...

NEW YORK — Young children might be able to overcome their peanut allergies if treated at an early enough age, according to a study published Thursday. The researchers gave increasing amounts of peanut ...

Researchers led by the Institut Pasteur, Université Paris, have developed a vaccine that elicits anti-Immunoglobulin E ...